| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 3.55e-04 | 20 | 28 | 2 | GO:0061665 | |
| GeneOntologyMolecularFunction | insulin receptor binding | 8.05e-04 | 30 | 28 | 2 | GO:0005158 | |
| GeneOntologyMolecularFunction | phospholipid binding | 8.90e-04 | 548 | 28 | 5 | GO:0005543 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 9.33e-04 | 316 | 28 | 4 | GO:0035091 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.16e-03 | 36 | 28 | 2 | GO:0019789 | |
| GeneOntologyMolecularFunction | protein transporter activity | 1.58e-03 | 42 | 28 | 2 | GO:0140318 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 3.73e-03 | 65 | 28 | 2 | GO:0004714 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | CALCOCO2 EIF2AK1 SYNJ1 PDGFRA MARCHF5 ALOX15 SPTBN1 BCL7C TECPR1 | 4.53e-05 | 1342 | 28 | 9 | GO:0033043 |
| Domain | - | 2.59e-04 | 391 | 28 | 5 | 2.30.29.30 | |
| Domain | PH_dom-like | 3.84e-04 | 426 | 28 | 5 | IPR011993 | |
| Domain | - | 4.89e-04 | 449 | 28 | 5 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 5.40e-04 | 459 | 28 | 5 | IPR013083 | |
| Domain | PH | 7.42e-04 | 278 | 28 | 4 | SM00233 | |
| Domain | PH_DOMAIN | 7.52e-04 | 279 | 28 | 4 | PS50003 | |
| Domain | PH_domain | 7.62e-04 | 280 | 28 | 4 | IPR001849 | |
| Domain | FYVE | 8.58e-04 | 29 | 28 | 2 | PF01363 | |
| Domain | FYVE | 8.58e-04 | 29 | 28 | 2 | SM00064 | |
| Domain | Znf_FYVE-rel | 1.18e-03 | 34 | 28 | 2 | IPR017455 | |
| Domain | Znf_FYVE_PHD | 1.35e-03 | 147 | 28 | 3 | IPR011011 | |
| Domain | Znf_FYVE | 1.47e-03 | 38 | 28 | 2 | IPR000306 | |
| Domain | ZF_FYVE | 1.63e-03 | 40 | 28 | 2 | PS50178 | |
| Domain | zf-RING_2 | 2.74e-03 | 52 | 28 | 2 | PF13639 | |
| Domain | PH | 4.75e-03 | 229 | 28 | 3 | PF00169 | |
| Domain | G-protein_beta_WD-40_rep | 7.17e-03 | 85 | 28 | 2 | IPR020472 | |
| Domain | TyrKc | 7.66e-03 | 88 | 28 | 2 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 7.66e-03 | 88 | 28 | 2 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 9.24e-03 | 97 | 28 | 2 | PS00109 | |
| Domain | Tyr_kinase_AS | 9.24e-03 | 97 | 28 | 2 | IPR008266 | |
| Domain | Znf_RING | 1.25e-02 | 326 | 28 | 3 | IPR001841 | |
| Domain | Pkinase_Tyr | 1.59e-02 | 129 | 28 | 2 | PF07714 | |
| Pubmed | Cbx4 Sumoylates Prdm16 to Regulate Adipose Tissue Thermogenesis. | 2.80e-05 | 10 | 28 | 2 | 29539416 | |
| Pubmed | 3.02e-05 | 1168 | 28 | 7 | 19946888 | ||
| Pubmed | Bimodal regulation of the PRC2 complex by USP7 underlies tumorigenesis. | 3.42e-05 | 11 | 28 | 2 | 33849069 | |
| Pubmed | Role for ephrinB2 in postnatal lung alveolar development and elastic matrix integrity. | 9.49e-05 | 18 | 28 | 2 | 18651661 | |
| Pubmed | Identification of novel protein kinases expressed in the myocardium of the developing mouse heart. | 1.18e-04 | 20 | 28 | 2 | 7893599 | |
| Pubmed | Distinct fibroblast lineages determine dermal architecture in skin development and repair. | 1.43e-04 | 22 | 28 | 2 | 24336287 | |
| Pubmed | NDP52 interacts with mitochondrial RNA poly(A) polymerase to promote mitophagy. | 1.85e-04 | 25 | 28 | 2 | 30309841 | |
| Pubmed | Identification of tyrosine kinases expressed in the male mouse gubernaculum during development. | 1.85e-04 | 25 | 28 | 2 | 15254900 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 2.11e-04 | 370 | 28 | 4 | 22922362 | |
| Pubmed | 2.52e-04 | 153 | 28 | 3 | 10718198 | ||
| Pubmed | Murine txk: a protein tyrosine kinase gene regulated by T cell activation. | 3.05e-04 | 32 | 28 | 2 | 7542761 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 3.46e-04 | 774 | 28 | 5 | 15302935 | |
| Pubmed | 4.32e-04 | 38 | 28 | 2 | 28680062 | ||
| Pubmed | 4.78e-04 | 40 | 28 | 2 | 30898150 | ||
| Pubmed | Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome. | 5.53e-04 | 43 | 28 | 2 | 34672947 | |
| Pubmed | Knockout mice with pituitary malformations help identify human cases of hypopituitarism. | 6.06e-04 | 45 | 28 | 2 | 38822427 | |
| Pubmed | Opposing LSD1 complexes function in developmental gene activation and repression programmes. | 6.33e-04 | 46 | 28 | 2 | 17392792 | |
| Pubmed | 6.72e-04 | 214 | 28 | 3 | 22199357 | ||
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 6.43e-04 | 31 | 22 | 2 | 81 | |
| GeneFamily | Ring finger proteins | 4.33e-03 | 275 | 22 | 3 | 58 | |
| GeneFamily | Fibronectin type III domain containing | 1.60e-02 | 160 | 22 | 2 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.62e-02 | 161 | 22 | 2 | 593 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.57e-02 | 206 | 22 | 2 | 682 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 4.28e-06 | 103 | 28 | 4 | M1170 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 5.77e-06 | 111 | 28 | 4 | MM1111 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-06 | 164 | 28 | 4 | b77995958c938e10a526118f75d78cee72e0b207 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.32e-05 | 141 | 28 | 3 | cabb5b8c0874813c713508af2ac620ab0d61ab6f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.32e-05 | 141 | 28 | 3 | 3fa3d2a8ebd9c285168ecea6db9cad74d3a3e85a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.72e-05 | 143 | 28 | 3 | 92ddc3e3f6ba78dd9daeb272c12503ec2650a874 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-HMOX1+_primitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.48e-04 | 165 | 28 | 3 | a040d18e4ba6da266440ad0b79990918770bfa7d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-04 | 171 | 28 | 3 | f21eae4dd2e0a566eff792d19367e96ffb0b74ba | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-04 | 171 | 28 | 3 | d428c2859a1efc284610ca241a6dae9f182309cd | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-erythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 173 | 28 | 3 | a8fb8db6061fa4d8d56a7b45004ecbd344501573 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-04 | 175 | 28 | 3 | 4d36da7399c62c170cb603957b35a35efb2c3fbe | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-04 | 175 | 28 | 3 | 2c39c1b112e873403ad2add8595cc256bf0b97a6 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.76e-04 | 175 | 28 | 3 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.76e-04 | 175 | 28 | 3 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-04 | 175 | 28 | 3 | e4c9b3c6bde390a3892b112b673f93e118220eb9 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Primitive_erythrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.79e-04 | 176 | 28 | 3 | 664a7d15563428d0ae156d97aa88415fd0a0506a | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 178 | 28 | 3 | b4e15c176875cd226854a0019495309d02730c42 | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic-erythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 178 | 28 | 3 | 9c4950357087212b2388116ba8866c359628694d | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 179 | 28 | 3 | 7e6da098976c7801d31dcc0201f813d2bc8b07fc | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.89e-04 | 179 | 28 | 3 | dfefa4b7ae0ee50cf67e0f1938c682f08a03ec53 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.89e-04 | 179 | 28 | 3 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-hematologic-erythrocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.89e-04 | 179 | 28 | 3 | 64672528f73ac0921f9c7df72e14ecbfac4d5270 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-hematologic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.89e-04 | 179 | 28 | 3 | fa0dd87111d399649cdea55f2e610ebc169e8a56 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.98e-04 | 182 | 28 | 3 | 1adb8d6404d50155e9f9ba805abef63929fe865f | |
| ToppCell | wk_08-11-Hematologic-Meg-ery|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.01e-04 | 183 | 28 | 3 | 7eecb8d80e31ca26c2e6ce43bf0f2c71be1643e4 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-04 | 186 | 28 | 3 | affc246a1091e44dc85a5e237c778a7541d5a2b4 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-04 | 186 | 28 | 3 | 40d1e15402fdfb3b5ae850a2070cd4b68fda3159 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-04 | 186 | 28 | 3 | e5014443e9d6e25943308483e20d48b776ae5373 | |
| ToppCell | Non-neuronal-Non-dividing-OPC|World / Primary Cells by Cluster | 2.21e-04 | 189 | 28 | 3 | 13848a031ab896b4b24c8319e4745b9b17ff9cfd | |
| ToppCell | Non-neuronal-Non-dividing-OPC-OPC|World / Primary Cells by Cluster | 2.21e-04 | 189 | 28 | 3 | ddf5be73912570c32c50f4ac2902da9b590526f8 | |
| ToppCell | Non-neuronal-Non-dividing-OPC-OPC-30|World / Primary Cells by Cluster | 2.21e-04 | 189 | 28 | 3 | 313d165fad541ec6e8dd524b88856e2c93eeb681 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 191 | 28 | 3 | 4187f31ec399b4c7c3608e94e3c32b7a54b1c3d4 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.28e-04 | 191 | 28 | 3 | 674e7a27b5f736f14f8513e5ef0d56e4e746d989 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.28e-04 | 191 | 28 | 3 | dd73173a898e29624acb22dd783339f3e696a213 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.28e-04 | 191 | 28 | 3 | 84c3ccc819fb5acec68daab2e6cc65d5d8909cc4 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 191 | 28 | 3 | 8e8bc200524a44ebe132f823ab7c15dac65d4952 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-OPC_related-OPC|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.32e-04 | 192 | 28 | 3 | 5d9bc234f01c73b2531edf8960588d5b6cf260a7 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-OPC_related|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.32e-04 | 192 | 28 | 3 | e6d115143ced6a0d9fe7c98acd3f730bac83f66b | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.35e-04 | 193 | 28 | 3 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.35e-04 | 193 | 28 | 3 | 305e15ee467826ee08b2617c69f250ad39c11b19 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.35e-04 | 193 | 28 | 3 | dd376664906caccc9c2065f8e7a364509e18a5cc | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-OPC_related|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.35e-04 | 193 | 28 | 3 | 80ae4d11e373e54ead919294786e0a8cbd11ea8a | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-OPC_related-OPC|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.35e-04 | 193 | 28 | 3 | 5c3b4cc1ca8439ac59ba00253903b9774dc048f8 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 194 | 28 | 3 | 0ef63abcfd057079a9a6f8b27404ff521d44845d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 194 | 28 | 3 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Mesenchymal-Unfolded_protein_responsible_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.42e-04 | 195 | 28 | 3 | 9873de83b67e9645112897d3391c2d9afaa9970e | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.50e-04 | 197 | 28 | 3 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | COVID-19-COVID-19_Mild-Others-RBC|COVID-19_Mild / Disease, condition lineage and cell class | 2.50e-04 | 197 | 28 | 3 | 3bae601e5d9689ea57e923814af8cdcae690becc | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.54e-04 | 198 | 28 | 3 | 01d563ccdc0da02dac04169e713844fecb4233a1 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.54e-04 | 198 | 28 | 3 | 827aa9d919bf6d670961e5501e17d351676127e3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.54e-04 | 198 | 28 | 3 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Control_saline-Epithelial_alveolar|Control_saline / Treatment groups by lineage, cell group, cell type | 2.54e-04 | 198 | 28 | 3 | 532b7ef4ad46fe35ad2c6bdf89f70a17f1a2e2e2 | |
| ToppCell | Influenza-Influenza_Severe-Others-RBC|Influenza_Severe / Disease, condition lineage and cell class | 2.57e-04 | 199 | 28 | 3 | da0fec0a492bc3827d9066d2590bcd466cd45564 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-CD4+_CTL|IIF / Disease, condition lineage and cell class | 2.57e-04 | 199 | 28 | 3 | 232f85175f49322eee903dd5e7d8e5a94c751ee0 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.61e-04 | 200 | 28 | 3 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 28 | 3 | fa1eaf008b54bdf7bbcdec8134460c5f64490de9 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 28 | 3 | f99e214eb680fd82a33f2b1524fbfca265d1cc42 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 28 | 3 | d85074b362b11e5a523a5325d203a61aa2759a7a | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary|LPS_only / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 28 | 3 | ce8281c9556a1f64f8ca8a029110077d4ef5b35e | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_only / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 28 | 3 | 83c4181c083b364f0d3a89ae7a0504781fa9fa9f | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_only / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 28 | 3 | f15baf287ec467664c23faa53fdea45257f7b9d0 | |
| Computational | Genes in the cancer module 80. | 6.56e-04 | 32 | 13 | 2 | MODULE_80 | |
| Computational | Genes in the cancer module 51. | 8.31e-04 | 36 | 13 | 2 | MODULE_51 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 3.30e-03 | 90 | 28 | 2 | DOID:11832 (biomarker_via_orthology) | |
| Disease | obesity (is_marker_for) | 4.14e-03 | 101 | 28 | 2 | DOID:9970 (is_marker_for) | |
| Disease | congestive heart failure (biomarker_via_orthology) | 4.63e-03 | 107 | 28 | 2 | DOID:6000 (biomarker_via_orthology) | |
| Disease | renal cell carcinoma (is_marker_for) | 6.56e-03 | 128 | 28 | 2 | DOID:4450 (is_marker_for) | |
| Disease | obesity (biomarker_via_orthology) | 8.56e-03 | 147 | 28 | 2 | DOID:9970 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IWYRGKWIRVERSRE | 106 | Q9Y276 | |
| WREVFYRLERWADRL | 116 | Q7LC44 | |
| YRWDRDVSQWKERGV | 2941 | P49792 | |
| ILWKTYFGRGRERRW | 26 | Q8N8L6 | |
| VVIWKQKPRYEIRWR | 546 | P16234 | |
| EEFVYKVWEGRWRVI | 81 | Q96A54 | |
| WRKRWFVLRRGRMSG | 26 | Q8WWW8 | |
| WFFWIRLYKIRRGRT | 391 | Q9NUN5 | |
| ELEERRKLYRWGNWK | 131 | P16050 | |
| GKMIRWEDYVLRLWR | 156 | Q9NX47 | |
| WLRTGFIWRRDVQRV | 91 | P54753 | |
| YEVSWDRLKRVWRRP | 466 | Q96FT7 | |
| SWRKRRWIEVYSLLR | 71 | Q9Y4C1 | |
| EKVRRWEKRWVTVGD | 26 | Q8WUZ0 | |
| LWDWIVERNKRGREY | 391 | Q9BQI3 | |
| IRKGRVEYLVKWRGW | 21 | O00257 | |
| RRKDWIGIFRVGWKT | 51 | Q13137 | |
| RIDRDSYSPRWKGRW | 956 | Q99590 | |
| GWIRSRKAVDWRLFR | 606 | Q08357 | |
| LVGLEKWTEYRVWVR | 671 | P10586 | |
| DRVLWRRRKWPFDRS | 806 | O43426 | |
| YWRGCVVRKWYRNLR | 196 | Q9H0A6 | |
| RARLEESRRLWKFFW | 631 | Q01082 | |
| RTVRVWLKRDSGQYW | 46 | Q96P53 | |
| RKWIRYRRYKSRDIW | 161 | Q7Z6L1 | |
| GREKRWQEREPTRVW | 206 | Q16560 | |
| RDQVCYRWSKRWLVV | 226 | O14939 | |
| RTIRVWLKRDSGQYW | 46 | Q8IWB7 |